Skip to main content
. Author manuscript; available in PMC: 2014 Oct 22.
Published in final edited form as: Neurotoxicology. 2008 Jun 19;29(6):971–977. doi: 10.1016/j.neuro.2008.06.003

Figure 6.

Figure 6

The effect of the selective norepinephrine transporter inhibitor, nisoxetine (A), and the selective serotonine transporter inhibitor, sertraline (B) on the toxicity of Tat 1-86 in primary rat fetal midbrain cell culture. Results presented as mean % of Calcein/Ethidium bromide fluorescence (Live/Dead ratio)vs non-treated control ± SEM, n of sister cultures analyzed = 6-12 per each variant of treatment. *- marks significant (P<0.05) difference between the treated group (50 nM Tat or 50 nM Tat + non-toxic dose of sertraline / nisoxetine) and non-treated control group.